Please login to the form below

Not currently logged in
Email:
Password:

Boehringer Ingelheim's John Pugh set for move to Accenture

Will take up London-based role in theconsultants' digital department

John Pugh Accenture Boehringer IngelheimBoehringer Ingelheim's global innovation team leader John Pugh is leaving the German pharmaceutical company at the end of this month to join Accenture.

He will take up a London-based role as a senior manger in its Interactive Digital Life Sciences department and report to Accenture Interactive's managing director Mark Prince.

Pugh spent 13 years at Boehringer, initially joining its UK affiliate as a new media producer and rising to communications manager.

In 2008 he moved to the company's headquarters in Ingelheim to lead its global innovation team in a position that saw him manage a team of 10 communications professionals.

During this time Pugh was responsible for setting up and operating the company's acclaimed social media strategy.

He also created the Facebook game Syrum, won two PM Society awards - in Digital Media and as Digital Pioneer, and picked up an eyeforpharma Digital Innovator award.

Pugh, who was most recently working on implementing a global SEO strategy for Boehringer, will start at Accenture on 24 September.

21st August 2015

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Ashfield

Ashfield, part of UDG Healthcare plc, is a global leader in commercialisation services for the healthcare industry. We partner with...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics